Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 312.85 Phase 4 studies.
21 CFR 312.85 Phase 4 studies., “Phase 4 studies”, is a CFR section of 21 CFR Part 312, Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses; in force.
https://ontology.bommaritollc.com/id/01a0f094-c4ae-77a9-9fac-9f11e4b982ec
Elsewhere
Facts
| adms:identifier | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 312.85 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Phase 4 studiesen |
| schema:url | |
| skos:prefLabel | 21 CFR 312.85 Phase 4 studies.en |